| 09:00 - 10:30 |
Concurrent scientific working group session II |
09:00 - 10:30
Axon 1 |
Stem cells in regenerative therapies
supported by Thermo Fisher Scientific
Chairs: Ludovic Vallier & Wolfgang Wagner |
| 09:00 - 09:30 |
T16 - Human pluripotent stem cell therapies to the heart and beyond: current status and challenges
Robert Zweigerdt, Hannover Medical School (MHH) |
| 09:30 - 09:45 |
T17 - Decoding neurovascular dysfunction in ADHD: Patient-specific iPSC-derived blood-brain barrier (BBB) models uncover hidden metabolic drivers beyond PARK2 genetics
Antje Appelt-Menzel, University Hospital Würzburg |
| 09:45 - 10:00 |
T18 - “Heps in a Bag”, an engineered hepatic patch against acute liver failure
Fabian Bachinger, Berlin Institute of Health (BIH) at Charité |
| 10:00 - 10:15 |
T19 - Off-the-shelf immune-shielded iPSC-derived CAR γδ T cells as novel cell therapy to treat hepatocellular carcinoma
Stephanie Sontag, Evotec |
| 10:15 - 10:30 |
T20 - Engineering basal cells to modulate epithelial-macrophage interactions in COPD
Lili Rusznyak, Helmholtz Munich |
09:00 - 10:30
Axon 2 |
Stem cells in aging & disease
Chairs: Michael Rieger & Andreas Trumpp |
|
| 09:00 - 09:30 |
T21 - Attenuation of stem cell aging to target aging-associated diseases
Hartmut Geiger, University Ulm |
| 09:30 - 09:45 |
T22 - A human brain organoid model of ageing identifies chromatin-mediated control of transposable elements during neural ageing
Elisa Gabassi, University of Innsbruck, Austria |
| 09:45 - 10:00 |
T23 - Extreme heterogeneity in hematologic aging is predominantly driven by stochastic variation, not by environmental nor genetic variation
Yiwen Zhang, German Cancer Research Center (DKFZ), Heidelberg |
| 10:00 - 10:15 |
T24 - Ontogenetically distinct bone marrow macrophages regulate HSC integrity and megakaryocyte-biased expansion
Nina Henning, Leibniz Institute on Aging (FLI), Jena |
| 10:15 - 10:30 |
T25 - Clonal trajectories of adult B-ALL in medullary sites and brain infiltration at single-cell resolution
Hui Ming Tew, University Hospital Frankfurt |
09:00 - 10:30
Dendrit 2 |
Stem cells in disease modeling & drug development I
Chairs: Oliver Brüstle & Bert Klebl |
| 09:00 - 09:30 |
T26 - Starting matters: quality and reproducibility in PSC-based research
Bert Klebl LDC Dortmund, Michael Peitz, University of Bonn, and Harald Stachelscheid, Berlin Institute of Health (BIH) |
| 09:30 - 09:45 |
T27 - Microglia modulate neurodevelopmental responses to micro- and nanoplastic exposure in human brain organoids
Nelli Blank-Stein, University of Bonn |
| 09:45 - 10:00 |
T28 - Dissecting the pathogenesis of Canavan disease using neuroglial organoids
Shreenidhi Vitchanthangal Prathivathibayankaram, University of Bonn |
| 10:00 - 10:15 |
T29 - Patient-specific iPSC-derived sensory neurons as a gateway to individualized neuropathic pain modeling and treatment
Anika Neureiter, RWTH Aachen |
| 10:15 - 10:30 |
T30 - In vitro/in silico reciprocal modeling of human neuronal networks reveals presynaptic vesicle dynamics underlying epileptiform activity
Jianbin Wen, University of Bonn |
09:00 - 10:30
Dendrit 1 |
ELSA symposium
Panel: Stepan Jerabek, Moderation: Tobias Cantz |
| 10:30 - 11:30 |
Break time / Industry exhibition supported by Evotec SE |
10:45 - 11:30
Axon 2 |
General Member Meeting
Executive Board & Managing Director
Heiko Lickert, Claudia Waskow, Sina Bartfeld, Michael Cross, Andreas Trumpp, Daniel Besser |
| 11:30 - 13:00 |
Industry session: "Technologies from GSCN industry partners" |
11:30 - 13:00
Axon 1 |
Main Supporter
Chairs: Michael Cross |
| 11:35 - 12:05 |
C01 - Streamlining advanced in vitro models: Principles and tools for stem cell-derived NAMs
Katharina Debowski, STEMCELL Technologies Germany GmbH |
| 12:05 - 12:25 |
C02 - Enabling the future of cell therapy: From discovery to the clinic
Beau le Roy, ACROBiosystems |
| 12:25 -12:45 |
C03 - Next-generation synthetic peptide growth factors/cytokines for regenerative medicine and cell therapy
Kazuki Shigematsu, PeptiGrowth Inc. |
11:30 - 13:00
Axon 2 |
Supporter II
Chairs: Mareike Albert |
| 11:35 - 11:50 |
C04 - Closing the analytical gap in cell therapy manufacturing: Automated at-line flow cytometry for QC from research to GMP release
Félix A. Montero-Julian, Biomerieux, Accellix |
| 11:50 - 12:05 |
C05 - Integrating patient data and hiPSC microglia to model Alzheimer’s disease for drug discovery
Henrik Renner, Evotec SE |
| 12:05 - 12:20 |
C06 - 3D bioreactor stem cell culture: Consistent from R&D to commercial manufacturing
Philipp Nold, Eppendorf SE |
| 12:20 - 12:35 |
C07 - Characterizing human PSC-derived cerebral organoids across imaging, cytometry, and sequencing
Hannah Johannsen, Miltenyi Biotec B.V. & Co. KG |
| 12:35 - 12:55 |
C08 - Unlocking the future of gene-modified cell therapy with non-viral lipid-based transfection
Nadia Mazzaro, Sartorius |
11:30 - 13:00
Dendrit 2 |
Supporter III
Chairs: Laura Steenpaß |
| 11:35 - 11:50 |
C09 - Watching stem cells live: Continuous live-cell imaging in iPSC and organoid research
Ceren Güneş, Countstar |
| 11:50 - 12:05 |
C10 - Interrogating inflammatory signaling in human iPSC-derived pancreatic ductal organoids with
a fully defined animal component-free matrix
Joel Cresser-Brown, bio-techne |
| 12:05 - 12:20 |
C11 - Advancing human relevant models: From AI-driven automated culture to high-content imaging and machine learning analysis - an end-to-end solution for iPSC and organoid workflows
Robert Storm, Molecular Devices Germany GmbH |
| 12:20 - 12:35 |
C12 - Building more relevant and reliable human iPSC-derived neuronal models with the new neurobasal PhysioPlus medium
David Kuniger, Thermo Fisher Scientific |
| 12:35 - 12:55 |
C13 - Innovative approaches and tools for investigating stem cell-based tissue culture
Francesca Aglialoro, Corning Life Sciences |
| 13:00 - 14:30 |
Lunch break / Industry exhibition
supported by Corning Life Sciences |
14:30 - 17:00
Axon 1/2 |
Presidential Symposium
Chair: Sina Bartfeld & Heiko Lickert |
| 14:30 - 15:15 |
Presidential Invite
PS1 - Stem cells, embryos and embryo models: from science to ethical concerns
Janet Rossant, The Hospital for Sick Children, Toronto, Canada |
| 15:15 - 15:45 |
GSCN 2026 Young Investigator Award
PS2 - Building towards understanding: from embryo models to principles of development (& back)
Jesse Veenvliet, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden |
| 15:45 - 16:30 |
K5 - Human intestinal organoids (HIOs) to study human intestine development, differentiation and disease
Jason Spence, University of Michigan, Ann Arbor, USA |
| 16:30 - 17:00 |
GSCN Publication of the Year 2025 - 2026 Award
PS4 - Pluripotent stem-cell-based screening uncovers sildenafil as a mitochondrial disease therapy
Annika Zink, Heinrich-Heine-University, Düsseldorf |
| 17:00 - 17:30 |
Break time / Industry exhibition
supported by Molecular Devices GmbH |
17:00 - 19:00
Haus 84
MDC.C:
- Foyer -
Mezzanine |
Poster session II - Poster number P088 - P171
supported by Eppendorf
(with beverages)
Pluripotency, differentiation & PSC-derived models (P088 – P135)
Stem cells in aging & disease (cancer stem cells) (P136 – P141)
Tissue-derived stem cells & organoids (P142 – P171)
Note: posters P150 - P171 will be displayed in the MDC.C foyer - Mezzanine.
Even numbers: 17:00 - 18:00
Odd numbers: 18:00 - 19:00 |
| 20:00 - 01:00 |
GSCN networking event for all participants (with bus transfer starting at 18:45)
supported by STEMCELL Technologies
The entrance fee is collected onsite.
Event location: ➚ Café am Neuen See, Berlin |